Synlett 2014; 25(4): 556-558
DOI: 10.1055/s-0033-1340495
letter
© Georg Thieme Verlag Stuttgart · New York

Iridium-Catalysed C–H Borylation Facilitates a Total Synthesis of the HRV 3C Protease Inhibitor (±)-Thysanone

Authors

  • Katrin Schünemann

    a   School of Chemical Sciences, The University of Auckland, 23 Symonds St., Auckland 1142, New Zealand   Fax: +64(9)3737422   Email: m.brimble@auckland.ac.nz
    b   Department of Molecular Medicine and Pathology, The University of Auckland, 85 Park Road, Auckland 1142, New Zealand
  • Daniel P. Furkert

    a   School of Chemical Sciences, The University of Auckland, 23 Symonds St., Auckland 1142, New Zealand   Fax: +64(9)3737422   Email: m.brimble@auckland.ac.nz
  • Stephen Connelly

    c   Department of Molecular Biology, The Scripps Research Institute, BCC 265, 10550 Torrey Pines Road, La Jolla, CA 92037, USA
  • John D. Fraser

    b   Department of Molecular Medicine and Pathology, The University of Auckland, 85 Park Road, Auckland 1142, New Zealand
  • Jonathan Sperry

    a   School of Chemical Sciences, The University of Auckland, 23 Symonds St., Auckland 1142, New Zealand   Fax: +64(9)3737422   Email: m.brimble@auckland.ac.nz
  • Margaret A. Brimble*

    a   School of Chemical Sciences, The University of Auckland, 23 Symonds St., Auckland 1142, New Zealand   Fax: +64(9)3737422   Email: m.brimble@auckland.ac.nz
Further Information

Publication History

Received: 14 October 2013

Accepted after revision: 02 December 2013

Publication Date:
10 January 2014 (online)


Graphical Abstract

Preview

Abstract

A new total synthesis of the HRV 3C protease inhibitor (±)-thysanone is described. The synthetic route hinges on an iridium-catalysed borylation to install the resorcinol-derived component of the natural product.

Supporting Information